Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WY✓SelectedUSD · WYGSK vs WY performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs WY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,742.6%
WY return
+612.4%
Excess return
+1,130.1%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioWYExcessAlpha
1D+0.5%+1.7%-1.2%+0.1%
7D+1.1%-0.8%+2.0%+1.3%
30D+6.3%+10.1%-3.8%+4.0%
3M+1.8%-15.4%+17.2%+5.5%
6M+1.7%-8.3%+10.0%+3.3%
YTD+6.5%-9.8%+16.4%+8.5%
1Y+9.5%-3.9%+13.4%+9.8%
3Y+65.3%-23.3%+88.6%+72.5%
5Y+43.7%-31.2%+74.9%+51.3%
10Y+104.1%+5.5%+98.6%+83.1%
All+1,742.6%+612.4%+1,130.1%+744.9%

Cumulative growth

Daily Returns

Daily percentage return beside WY.

Daily Out/Under-Performance

Portfolio return minus WY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded WY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling